Lectenz Bio awarded NIH NIGMS SBIR Phase I

Related Posts

• 
  Lectenz Bio receives NIH NIGMS SBIR Phase I

  The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop fucose binding…

• 
  Lectenz Bio receives NIH SBIR Phase II

  The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop…

• 
  Lectenz Bio receives NIH SBIR Phase I

  The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio a second SBIR Phase I to apply…